HomeCompareADMP vs O

ADMP vs O: Dividend Comparison 2026

ADMP yields 258.06% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADMP wins by $563.86M in total portfolio value
10 years
ADMP
ADMP
● Live price
258.06%
Share price
$0.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$563.90M
Annual income
$319,983,732.54
Full ADMP calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — ADMP vs O

📍 ADMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADMPO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADMP + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADMP pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADMP
Annual income on $10K today (after 15% tax)
$21,935.48/yr
After 10yr DRIP, annual income (after tax)
$271,986,172.66/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, ADMP beats the other by $271,981,839.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADMP + O for your $10,000?

ADMP: 50%O: 50%
100% O50/50100% ADMP
Portfolio after 10yr
$281.97M
Annual income
$159,994,415.37/yr
Blended yield
56.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

ADMP
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-59.7
Piotroski
3/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADMP buys
0
O buys
0
No recent congressional trades found for ADMP or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADMPO
Forward yield258.06%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$563.90M$34.2K
Annual income after 10y$319,983,732.54$5,098.20
Total dividends collected$538.16M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: ADMP vs O ($10,000, DRIP)

YearADMP PortfolioADMP Income/yrO PortfolioO Income/yrGap
1← crossover$36,506$25,806.45$10,818$607.86+$25.7KADMP
2$127,109$88,046.91$11,786$741.30+$115.3KADMP
3$422,514$286,507.78$12,944$910.50+$409.6KADMP
4$1,342,148$890,057.94$14,343$1,127.28+$1.33MADMP
5$4,078,469$2,642,370.06$16,053$1,408.17+$4.06MADMP
6$11,868,198$7,504,236.72$18,167$1,776.65+$11.85MADMP
7$33,107,440$20,408,468.42$20,815$2,266.60+$33.09MADMP
8$88,631,800$53,206,838.59$24,179$2,927.66+$88.61MADMP
9$227,957,353$133,121,327.57$28,521$3,833.95+$227.93MADMP
10$563,898,101$319,983,732.54$34,218$5,098.20+$563.86MADMP

ADMP vs O: Complete Analysis 2026

ADMPStock

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Full ADMP Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this ADMP vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADMP vs SCHDADMP vs JEPIADMP vs KOADMP vs MAINADMP vs STAGADMP vs ADCADMP vs NNNADMP vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.